Hematopoietic Stem Services Available In Virginia
-
based in USA
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this paradigm is limited by the expression of tumor targets on healthy cells, resulting in on-target toxicity. On-target toxicity has led to the development failure of many ...
-
Manufactured by Creative Biogenebased in USA
MMLV retrovirus has been broadly used for gene transduction in a variety of cells. However, expression of genes mediated by MMLV retrovirus can be repressed in many cell types including embryonic stem (ES), embryonal carcinoma (EC) and hematopoietic stem (HS) cells. The transcriptional repression is mainly caused by DNA methylation. ...
-
Manufactured by Neovii Pharmaceuticals AGbased in SWITZERLAND
, and/or hematopoietic stem cell ...
-
Manufactured by Pluristem Therapeutics Inc.based in ISRAEL
Bone marrow deficiency refers to a condition in which the hematopoietic stem cells in the bone marrow fail to produce enough, or produce abnormal, red blood cells, white blood cells and platelets. Hematopoietic cell transplantation (HCT), the transplantation of multipotent hematopoietic cells, is a standard treatment in various ...
-
Manufactured by Mesoblast Ltd.based in AUSTRALIA
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as it develops its product candidates for major markets including the United States, Europe, Japan and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you